Member info
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/09/john-doe.jpg)
Pr Luca Rossetti
Italy
Team
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/09/john-doe.jpg)
Dr Leonardo Colombo
Italy
HCP Center
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/11/Ospedale_San_Paolo_di_Milano-430x160.jpg)
contact
ASST Santi Paolo e Carlo, Milan, Italy
Clinical trials
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/08/ern-picto-500-230x230.jpg)
An Open Label, Multi-centre, Phase I/II Dose Escalation Trial of a Recombinant Adeno-associated Virus Vector (AAV2-.RPGR) for Gene Therapy of Adults and Children With X-linked Retinitis Pigmentosa Owing to Defects in Retinitis Pigmentosa GTPase Regulator (RPGR)
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/08/ern-picto-500-230x230.jpg)
Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/08/ern-picto-500-230x230.jpg)
Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/08/ern-picto-500-230x230.jpg)
Natural history of patients with inherited retinal diseases due to mutations in RPE65 gene
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/08/ern-picto-500-230x230.jpg)
A Dose Ranging Study to Evaluate the Safety and Potential Efficacy ofrhNGF in Patients With Retinitis Pigmentosa (RP)
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/08/ern-picto-500-230x230.jpg)
Global Patient Registry of Inherited Retinal Disease
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/08/ern-picto-500-230x230.jpg)
Global Patient Registry of Inherited Retinal Disease